Warning letter
ADAO, Inc. [ARCHIVED]: warning letter of May 6, 2011
FDA warning letter UCM256413 · Denver District Office
Key facts
| Reference number | UCM256413 |
|---|---|
| Company | ADAO, Inc. [ARCHIVED] |
| Subject | CGMP For Manfacturing, Processing, Packing, Storage & Holding/Adulterated |
| Issue date | May 6, 2011 |
| Posted date | May 6, 2011 |
| Issuing office | Denver District Office |
| Product type | Unknown |
| CFR sections cited | 101, 101.4, 101.5, 110, 101.4(b)(2), 110.20(a)(1), 110.20(b)(7), 110.35(c), 110.80(b)(5) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: